PathogenDx, Inc – Trademark Portfolio
Entity Type: 03
PathogenDx, Inc holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 17 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include PATHOGENDX and SETTING THE STANDARD IN DNA TESTING. The owner is based in Scottsdale, AZ.
9375 E. Shea Blvd, Suite 100
Scottsdale, AZ 85260
Showing of trademarks Trademarks
Trademark Classifications
PathogenDx, Inc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does PathogenDx, Inc have?
PathogenDx, Inc has 17 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 11 abandoned, 1 cancelled.
What trademark classes does PathogenDx, Inc file in?
PathogenDx, Inc files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are PathogenDx, Inc's most well-known trademarks?
PathogenDx, Inc's registered trademark portfolio includes well-known marks such as PATHOGENDX and SETTING THE STANDARD IN DNA TESTING. These are among 3 currently registered trademarks in the portfolio.
What is PathogenDx, Inc's trademark registration success rate?
PathogenDx, Inc has a 20% trademark registration rate, with 3 out of 15 resolved applications resulting in successful registration. Currently, 2 applications are pending review.